Tailored formulation development for your drug product.
Quotient Sciences’ formulation teams have vast experience and a proven track record across an array of drug product formats for administration via oral, inhaled, topical, rectal and parenteral routes. We are trusted experts in formulation design.
Over 30 years of formulation development expertise
We have more than 30 years of experience developing a breadth of formulation services for small molecules and synthetic peptides, across a range of indications. With expertise in simple and complex dosage forms, we have formulated over 1,500 molecules.
Solid oral dosage forms
- API or formulated API in a bottle or capsule
- Immediate, modified, and sustained release tablets
- Multiparticulates, mini-tablets and granules
- Liquid filled capsules
- Orally disintegrating tablets (ODT)
Inhaled & nasal dosage forms
- Dry powders
- Solutions
- Suspensions
Parenteral dosage forms
- Intravenous (IV)
- Intramuscular (IM)
- Subcutaneous (SC)
Gels, ointments & creams
- Topical
- Rectal
Oral Liquids
- Aqueous and non-aqueous liquids
- Suspensions and nanosuspensions
Your partner in formulation development
Our track record in clinical research means we know what it takes to develop formulations across the full development pathway from preclinical to late stage. From fit-for-purpose preclinical and first-in-human (FIH) dosage forms to optimized drug products for late-stage development and market, we work with you to develop the most appropriate formulation based on the physicochemical and biopharmaceutics properties of your molecule.
A breadth of formulation capabilities
With over 30 years of experience, we provide full-service support for small molecule drug programs, from dosage formulation development to GMP clinical trial manufacturing and commercial drug product supply.
Identify and address critical formulation issues quickly
We focus on delivering the most appropriate formulations, however complex, to expedite your clinical program. We support rapid progression to your first-in-human evaluation and ensure that your lead drug product can be seamlessly transitioned through development and scale-up. Using our expertise, we help you identify any issues that would impede scale up, so you can be set up for commercial success.
Upgraded US and UK facilities
We have state-of-the-art, recently upgraded pharmaceutical development and clinical manufacturing facilities in the US and UK.
Optimize the performance of your formulation
Our unique approach to drug product optimization saves time and increases the potential for success by facilitating decisions based on real-time clinical data. We have completed over 300 drug product formulation optimization programs and have clinically evaluated more than 1,000 formulations.
Over 30 years of experience in formulation development
We have deep expertise in formulation development, built across more than 30 years and over 1,500 molecules developed.
Formulation development support from preclinical to late-stage clinical evaluation
Our innovative approach to formulation development is based on our proven track record in delivering phase-appropriate formulations across the product development pathway, from preclinical to late-stage development.
Formulation Development Services
Explore our services and programs for small molecule & peptide drug development.
